Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H D Edington

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The American Journal of Physiology|October 12, 1999
Impaired wound healing and angiogenesis in eNOS-deficient miceP C Lee, A N Salyapongse, G A Bragdon, et al.
Oncogene|February 14, 2007
SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomasS J Moschos, A P Smith, M Mandic, et al.
Molecular Medicine (Cambridge, Mass.)|March 11, 1999
Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesionsJ M Kirkwood, D L Farkas, A Chakraborty, et al.
Cancer|June 28, 2000
Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanomaJ M Kirkwood, R A Mascari, H D Edington, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1996
Molecular analysis of melanoma precursor lesionsY Wang, U Rao, R Mascari, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1994
Recombinant IL-12 administration induces tumor regression in association with IFN-gamma productionC L Nastala, H D Edington, T G McKinney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignanciesM B Atkins, M J Robertson, M Gordon, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The American Journal of Physiology|October 12, 1999
Impaired wound healing and angiogenesis in eNOS-deficient miceP C Lee, A N Salyapongse, G A Bragdon, et al.
Oncogene|February 14, 2007
SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomasS J Moschos, A P Smith, M Mandic, et al.
Molecular Medicine (Cambridge, Mass.)|March 11, 1999
Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesionsJ M Kirkwood, D L Farkas, A Chakraborty, et al.
Cancer|June 28, 2000
Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanomaJ M Kirkwood, R A Mascari, H D Edington, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1996
Molecular analysis of melanoma precursor lesionsY Wang, U Rao, R Mascari, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1994
Recombinant IL-12 administration induces tumor regression in association with IFN-gamma productionC L Nastala, H D Edington, T G McKinney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignanciesM B Atkins, M J Robertson, M Gordon, et al.
Pageof 2